Health Care: Health Services

TearLab Corp (TEAR: NASDAQ)

$3 n/a | n/a%
10/21/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 3.00
52 Week High 11.64
52 Week Low 2.95
Avg. Daily Vol. (Mil) 0.27
Beta (3 year) 3.45
Share Related Items
Mkt Cap (Mil) 100.77
Shares Out (Mil) 33.59
Float (Mil) 26.31
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.50
Current Ratio 6.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.64
Price/Book 2.88
Price/Cash Flow -5.90
Per Share Data
Earnings -0.57
Sales 0.53
Book Value 1.04
Cash Flow -0.50
Business Summary
TearLab Corp is an in-vitro diagnostic company. It commercializes a proprietary tear testing platform that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film.
General Information
9980Huennekens Street
Suite100
San Diego, CA 92121
www.tearlab.com
Industry : Health Services
Sector: Health Care
Employees: 101
CEO: Elias Vamvakas
Short Interest
Current Month (Mil) 5.51
Previous Month (Mil) 5.76
Short Interest Ratio (Days) 30.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -48.10
Return on Investments -55.30
Profitability
Gross Margin 54.50
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with TEAR

Latest TEAR Headlines from TheStreet

More Financial News for TEAR

Press Releases for TEAR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter